• 1
    Sant M, Capocaccia R, Verdecchia A, Estève J, Gatta G, Micheli A, Coleman MP, Berrino F, EUROCARE Working Group. Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. Int J Cancer 1998; 77: 67983.
  • 2
    Quinn MJ, Martinez-Garcia C, Berrino F, EUROCARE Working Group. Variations in survival from breast cancer in Europe by age and country, 1978–1989. Eur J Cancer 1998; 34: 220411.
  • 3
    Sant M and the EUROCARE Working Group. Differences in stage and therapy for breast cancer across Europe. Int J Cancer 2001; 93: 894901.
  • 4
    Sant M, Gatta G. The EUROCARE database. In: BerrinoF, SantM, VerdecchiaA, CapocacciaR, HakulinenT, Est;èveJ, eds. Survival of cancer patients in Europe: the EUROCARE study. IARC Scientific Publications No. 132. Lyon: IARC, 1995. 1531.
  • 5
    Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 16048.
  • 6
    Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JWW, Damhuis RAM, Faivre J, Martinez-Garcia C, Pawlega J, Ponz de Leon M, Pottier D, Raverdy N, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000; 47: 5338.
  • 7
    Spiessel B, Beahers OH, Hermanek P, Hutter RVP, Schieber O, Sobin LH, Wagner G. UICC: TNM atlas classification of malignant tumours, 3rd ed. Berlin: Springer, 1992.
  • 8
    Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Comp Prog Biomed 1985; 19: 197207.
  • 9
    Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Accepted for publication in Statistics and Medicine, 2003.
  • 10
    Gloeckler Ries LA, Henson DE, Harras A. Survival from breast cancer according to tumour size and nodal status. Surg Oncol Clin N Am 1994; 3: 3553.
  • 11
    Shetty MR, Reiman HM. Tumour size and axillary metastasis, a correlative occurrence in 1244 cases of breast cancer between 1980 and 1995. Eur J Surg Oncol 1997; 23: 13941.
  • 12
    Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA 1994; 271: 11638.
  • 13
    Shapiro S, Coleman EA, Broeders M, Codd M, de Koning H, Fracheboud, Moss S, Paci E, Stachenko S, Ballard-Barbash R. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epidemiol 1998; 27: 73542.
  • 14
    Adami HO, Malker B, Holmberg L, Persson I, Stone B. The relation between survival and age at diagnosis in breast cancer. N Eng J Med 1986; 315: 55963.
  • 15
    Mohle-Boetani J, Grosser S, Malec M, Whittemore AS. Survival advantage among patients with breast cancer diagnosed at 45 to 49 years of age. N Eng J Med 1986; 315: 587.
  • 16
    Coleman MP, Babb P, Damiecki P, Grosclaude P, Honjo S, Jones J, Knere G, Pitard A, Quinn M, Slogett A, De Stavola B. Cancer survival trends in England and Wales 1971–1995: deprivation and NHS region. Series SMPS No. 61. London: The Stationery Office, 1999.
  • 17
    Chouillet AM, Bell CMJ, Hiscox JC. Management of breast cancer in southeast England. BMJ 1994; 308: 16871.
  • 18
    Berrino F, Capocaccia R, Estève J, Gatta G, Hakulinen T, Micheli A, Sant M, Verdecchia A. Survival of cancer patients in Europe: the EUROCARE-2 study. IARC Scientific Publications No. 151. Lyon: International Agency for Research on Cancer, 1999.
  • 19
    Aareleid T, Rahu M. Cancer survival in Estonia from 1978 to 1987. Cancer 1991; 68: 208892.
  • 20
    Karjalainen S, Aareleid T, Hakulinen T, Pukkala E, Rahu M, Tekkel M. Survival of female breast cancer patients in Finland and in Estonia: stage at diagnosis important determinant of the difference between countries. Soc Sci Med 1989; 28: 2338.
  • 21
    Vercelli M, Capocaccia R, Quaglia A, Casella C, Puppo A, Coebergh JW. Relative survival in elderly European cancer patients: evidence for health care inequalities. Crit Rev Oncol Hematol 2000; 35: 16179.
  • 22
    Nab HW, Hop WCJ, Crommelin MA, Kluck HM, Coebergh JWW. Improved prognosis of breast cancer since 1970 in southeastern Netherlands. Br J Cancer 1994; 70: 2858.
  • 23
    Voogd AC, Van Beek MW, Crommelin MA, Kluck HM, Repelaer van Driel OJ, Coebergh JWW, on behalf of the regional Breast Cancer Study Group. Management of early breast cancer in southeast Netherlands since 1984. A population-based study. Acta Oncol 1994; 33: 7537.
  • 24
    Coebergh JWW, Janssen M, Louwman M, Voogd A. Cancer incidence, care and survival in the South of Netherlands 1955–1999. Eindhoven: IKZ, 2001.
  • 25
    Louwman WJ, van Diest PJ, van Beek MW, Schapers RFM, Nolthenius-Puylaert TM, Baak JPA, Coebergh JWW. Trends in breast cancer aggressiveness before the introduction of mass screening in southeastern Netherlands 1975–89. Breast Cancer Res Treatment 2002; 73: 199206.
  • 26
    Gatta G, Buiatti E, Conti E, De Lisi V, Falcini F, Federico M, Gafà L, Ponz de Leon M, Vercelli M, Zanetti R. Variations in the survival of adult cancer patients in Italy. Tumori 1997; 83: 490496.
  • 27
    European Network of Cancer Registries. EUROCIM version 4.0. European Incidence database V2.3. ICD-10 dictionary (2001). Lyon: IARC, 2001.